Risks for hepatitis B transmission are common among prisoners, and routine hepatitis B vaccination is recommended for all incarcerated individuals.
However, the exact prevalence of current and past hepatitis B infection and related liver disease is unknown in prisons within Victoria. Vaccination coverage among prisoners is also currently unknown.
Finally, prevalence of hepatitis D, a virus that requires hepatitis B to replicate, is also unknown among prisoners.
In this study, the seroprevalence of current and past hepatitis B and D infection among prisoners and associated clinical risks for disease will be determined by retrospective analysis of a clinical database.
Estimates of vaccine coverage within prisons will also be made, with a view to informing health policy.
This study involves quantitative analysis of data from a clinical database (data already collected but will require cleaning).
This website was developed with the generous support of a donor.
Burnet Institute (Australia) is located on the traditional land of the Boon Wurrung people and we offer our respects to their Elders past and present. We recognise and respect the continuation of cultural, spiritual and educational practices of Aboriginal and Torres Strait Islander peoples of this land.
Oops!
It looks like something may have gone wrong, and some of the resources required to load the page may not have loaded correctly.
